Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
16–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Individuals at least 16 years of age infected with HIV-1
CD4 lymphocyte count less than equal to (\<=) 100 cells per cubic millimeter (cells/mm\^3) and HIV-1 ribonucleic acid (RNA) viral load greater than equal to (\>=) 10,000 copies/mL while on highly active antiretroviral therapy (HAART)
Genotypic or phenotypic resistance and/or treatment-limiting toxicity on previous antiretroviral regimens
You may not be if
Evidence of ongoing alcohol and/or drug or substance abuse
Prior non-adherence to antiretroviral treatment regimens
Evidence of active, untreated opportunistic infection, intercurrent illness, drug toxicity or any other condition.
Clareo Health | A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection
